FDA NDC Directory · JSON-LD · Markdown

Ontruzant

NDC 78206-147 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nametrastuzumab
Labeler / ManufacturerOrganon LLC
Marketing categoryBiologic License Application · App BLA761100
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRASTUZUMAB (150 mg/1)
Marketing started20210601
Package count1

External sources

Source: openFDA. Public-domain (CC0).